PerkinElmer
American corporation focused in life science research
PKI NYSE
ISIN US7140461093 SEC CIK 31791 LEI 549300IKL1SDPFI7N655
Follow PerkinElmer
Weekly email: filings, results, news
Revenue, last quarter
$729.7M
+1.3% vs same quarter last year
Net income
$51.8M
−3.9% vs same quarter last year
EPS, diluted
$0.47
+2.2% vs same quarter last year
Operating cash flow
$191.9M
+42.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.9B | $241.2M |
| FY24 | $2.8B | $270.4M |
| FY23 | $2.8B | $693.1M |
| FY22 | $3.3B | $569.2M |
| FY21 | $3.8B | $943.2M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | 12.5% | 8.4% |
| FY24 | 12.6% | 9.8% |
| FY23 | 10.9% | 25.2% |
| FY22 | 22.4% | 17.2% |
| FY21 | 32.9% | 24.6% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $509.4M |
| FY24 | $541.7M |
| FY23 | $9.9M |
| FY22 | $594.2M |
| FY21 | $1.3B |
- PerkinElmer
- Technology median
Show the numbers
| Year | PerkinElmer | Technology median |
|---|---|---|
| FY25 | 8.4% | −0.4% |
| FY24 | 9.8% | −2.7% |
| FY23 | 25.2% | −7.5% |
| FY22 | 17.2% | −7.3% |
| FY21 | 24.6% | −4.6% |